We are live on ! Find out more
SBWIC

Schaper Benz & Wise Investment Counsel Portfolio holdings

AUM $1.5B
1-Year Est. Return 31.02%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+31.02%
3 Year Est. Return
+83.38%
5 Year Est. Return
+96.2%
10 Year Est. Return
+357.25%
AUM
$449M
AUM Growth
+$17.5M
Cap. Flow
-$14.4M
Cap. Flow %
-3.21%
Top 10 Hldgs %
30.29%
Holding
94
New
5
Increased
21
Reduced
52
Closed
2

Top Buys

Rank Stock Value
1
SO icon
Southern Company
SO
+$1.59M
2
ABT icon
Abbott
ABT
+$897K
3
ALTR
Altera Corp
ALTR
+$699K
4
CSCO icon
Cisco
CSCO
+$668K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$534K

Top Sells

Rank Stock Value
1
MOLXA
MOLEX INC CL-A
MOLXA
+$12.2M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.71M
3
ABBV icon
AbbVie
ABBV
+$489K
4
NBL
Noble Energy, Inc.
NBL
+$409K
5
BGS icon
B&G Foods
BGS
+$390K

Sector Composition

Rank Sector Weight
1 Technology 19.31%
2 Financials 18.62%
3 Healthcare 17.58%
4 Consumer Staples 7.29%
5 Communication Services 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROW icon
26
T. Rowe Price
TROW
$24.4B
$8.45M 1.88%
100,912
-100
-0.1% -$7.83K
ORCL icon
27
Oracle
ORCL
$425B
$8.18M 1.82%
213,658
+895
+0.4% +$30.8K
BMS
28
DELISTED
Bemis
BMS
$7.51M 1.67%
183,360
-3,528
-2% -$139K
MDT icon
29
Medtronic
MDT
$115B
$7.08M 1.58%
123,305
-2,155
-2% -$122K
WU icon
30
Western Union
WU
$2.2B
$6.95M 1.55%
402,630
-20,000
-5% -$350K
PFE icon
31
Pfizer
PFE
$155B
$6.76M 1.51%
232,577
-5,039
-2% -$147K
NFX
32
DELISTED
Newfield Exploration
NFX
$6.25M 1.39%
253,715
-1,580
-0.6% -$44.3K
EXAC
33
DELISTED
Exactech Inc
EXAC
$6.01M 1.34%
252,884
-6,558
-3% -$150K
ABT icon
34
Abbott
ABT
$190B
$5.76M 1.28%
150,266
+24,340
+19% +$897K
SE
35
DELISTED
Spectra Energy Corp Wi
SE
$5.31M 1.18%
149,110
-1,725
-1% -$59.4K
HD icon
36
Home Depot
HD
$354B
$5.07M 1.13%
61,616
-1,847
-3% -$144K
MRK icon
37
Merck
MRK
$326B
$5.02M 1.12%
105,167
-2,070
-2% -$94.6K
WRI
38
DELISTED
Weingarten Realty Investors
WRI
$4.48M 1%
163,386
+9,651
+6% +$285K
AAPL icon
39
Apple
AAPL
$4.48T
$4.19M 0.93%
209,104
+3,640
+2% +$68.8K
DUK icon
40
Duke Energy
DUK
$95B
$4.07M 0.91%
58,951
-2,575
-4% -$180K
TEVA icon
41
Teva Pharmaceuticals
TEVA
$42.6B
$3.92M 0.87%
97,725
-43,436
-31% -$1.71M
SBUX icon
42
Starbucks
SBUX
$121B
$3.88M 0.86%
98,870
+200
+0.2% +$7.91K
WR
43
DELISTED
Westar Energy Inc
WR
$3.45M 0.77%
107,200
-1,850
-2% -$58.4K
TFC icon
44
Truist Financial
TFC
$63.6B
$3.38M 0.75%
90,690
+1,800
+2% +$62.2K
NKE icon
45
Nike
NKE
$61.2B
$3.24M 0.72%
82,380
-800
-1% -$30.6K
XOM icon
46
ExxonMobil
XOM
$657B
$2.82M 0.63%
27,833
– –
MRSH
47
Marsh
MRSH
$90.9B
$2.66M 0.59%
54,965
-750
-1% -$34.8K
MSFT icon
48
Microsoft
MSFT
$3.73T
$2.24M 0.5%
59,786
+555
+0.9% +$20.2K
TSS
49
DELISTED
Total System Services, Inc.
TSS
$1.9M 0.42%
57,165
-610
-1% -$18.7K
ABBV icon
50
AbbVie
ABBV
$441B
$1.89M 0.42%
35,746
-9,950
-22% -$489K
1
2
3 4

Similar funds

SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's Q4 2013 Portfolio in Review

As of Q4 2013, Schaper Benz & Wise Investment Counsel held 94 positions worth $449M, up 4.1% from $431M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Schaper Benz & Wise Investment Counsel withdrew a net $14.4M in Q4 2013, closing 2 positions and reducing 52 holdings. Its most notable exit was MOLEX INC CL-A, an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Schaper Benz & Wise Investment Counsel opened a new position in Southern Company worth $1.58M.

  • Schaper Benz & Wise Investment Counsel's largest Q4 2013 buy was Southern Company: 38,450 shares worth $1.58M.
  • Schaper Benz & Wise Investment Counsel added most to Abbott in Q4 2013, an estimated $897K increase.
  • Schaper Benz & Wise Investment Counsel's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $1.71M.
  • Schaper Benz & Wise Investment Counsel fully exited MOLEX INC CL-A in Q4 2013, selling an estimated $12.2M.
  • Schaper Benz & Wise Investment Counsel's ten largest holdings make up 30% of its $449M portfolio in Q4 2013.
  • Schaper Benz & Wise Investment Counsel opened 5 new positions and closed 2 in Q4 2013.
  • Schaper Benz & Wise Investment Counsel's portfolio value rose 4.1% quarter-over-quarter to $449M.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q4 2013, filed 31 Jan 2014.